drugset / Trial / NCT06842277

Treatment of Deficient Interdental Papilla Using Albumin-platelets Rich Fibrin

NCT06842277 ↗

Phase 2 Active not recruiting 10 enrolled Cairo University
NaSingle-groupOpen-labelTreatment

Summary

The goal of this ( A case series, clinical trial ) is treatment of deficient interdental papilla in patients who have interdental papillary loss class 1 or 2 in maxillary or mandibular anterior region with plaque index and gingival index less than 1 and the selected sites had distance between contact point and inter proximal bone crest less than 7mm and probing depth less than 4mm. Hypothesis: Albumin-PRF is an efficient treatment of deficient interdental papilla. The primary outcome ( distance between the contact point and papillary tip will be measured by periodontal probe) The participants will practice good oral hygiene measures

Timeline

Start
2025-02-18
Primary completion
2025-12-30
Completion
2026-04

Drugs

EvaluationDrugModalityDoseRoute
Subject Injectable albumin platelets rich fibrin Unknown — Other

Indications